Adults 18–65 with a history of high blood pressure that remains elevated despite treatment may qualify for a study evaluating an investigational medication designed to help lower blood pressure.
Uncontrolled Hypertension
Age Range:
18 to 65
Gender:
Male and Female
Location:
Rochester, New York
About the Study
This research study is evaluating an investigational use of iloperidone, a medication currently approved for certain psychiatric conditions, to determine whether it may also help lower blood pressure. Researchers will assess how effective the study drug is compared to placebo and evaluate its safety and tolerability in adults with uncontrolled hypertension.
Qualifications
You may be able to join if you:
- Are 18 to 65 years old.
- Have a history of hypertension and are currently taking blood pressure medication but still have elevated readings.
- Have been on stable antihypertensive treatment for at least 8 weeks.
- Do not have severe or uncontrolled cardiovascular conditions or very high blood pressure requiring urgent treatment.
- Do not have significant kidney disease or other serious medical conditions that may affect participation.
- Do not have certain psychiatric or neurological conditions such as schizophrenia or seizure disorders.
FEATURED STUDIES
Adults with osteoarthritis (OA) knee pain may qualify for a research study evaluating an investigational medication for chronic pain relief.
Adults 18 to 75 years of age may qualify for a research study evaluating an investigational medication for migraine attacks.
Adults ages 18 to 70 who experience episodic migraine may qualify for a clinical research study evaluating an investigational medication […]
A vaccine research study is expected to open for enrollment in the coming weeks. Join our notification list to be […]
Adults 18 years and older may qualify for a study evaluating investigational treatment options for diabetic peripheral neuropathic pain (DPNP), […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]